Scott Gottlieb is skeptical of the science behind CBD supplements

An insider's guide to the politics and policy of health care.

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Scott Gottlieb has a lot of thoughts on CBD

When I chatted with the former FDA commissioner about the agency’s efforts to regulate CBD, one thing was crystal clear: Gottlieb probably isn’t going to be offered a job as the head of the CBD lobby any time soon.

“There’s no science to demonstrate that putting it in the

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Opinion: It’s Time To Change The Definition Of ‘Health’
Rather than pursuing the "absence" of disease, we need a more inclusive definition of health — one that works for more people.
STAT4 min read
Opinion: State Drug Importation Programs Will Work With The FDA, Not Outside Of It
State programs can use the global pharmaceutical supply chain to relieve the sometimes crushing financial burden of drug treatments — at least until we have an effective national approach to…
STAT5 min readSociety
Opinion: I Wanted To Try Medical Marijuana. Why Couldn’t My Doctors Help Me?
Until we make it easier to study the effects of #medicalmarijuana and #cannabis, and train doctors about its benefits and risks, people who could benefit from it will continue to…